These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8099452)

  • 21. [Proliferating cell nuclear antigen (PCNA/cyclin) in gastric carcinoma in relation to its prognosis].
    Li N
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):34-6. PubMed ID: 8101481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer.
    Fujii M; Motoi M; Saeki H; Aoe K; Moriwaki S
    Acta Med Okayama; 1993 Apr; 47(2):103-8. PubMed ID: 8099466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
    Mangham DC; Rowlands DC; Newbold KM; Reynolds GM; Fielding JW; Hallissey MT
    J Clin Pathol; 1994 May; 47(5):473-4. PubMed ID: 7913101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S; Kroll S; Char DH; Frigillana H
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
    Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
    Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
    Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of proliferating cell nuclear antigen in invasive ductal carcinoma of the breast.
    Horiguchi J; Iino Y; Takei H; Morishita Y; Nakajima T
    Jpn J Clin Oncol; 1994 Apr; 24(2):79-84. PubMed ID: 7908995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
    Takamura H; Yonemura Y; Hirono Y; Ninomiya I; Sahara H; Tsugawa K; Matsumoto H; Sugiyama K; Fujimura T; Nishimura G
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The evaluation of cellular proliferating activity in gastric carcinoma with the proliferating cell nuclear antigen (PCNA) expressive rate: its fundamental examination of the immunohistochemical procedures and its clinical applications].
    Nakano H; Namatame K; Nakayoshi A; Kumada K
    Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):580-92. PubMed ID: 8101959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome.
    Amin MB; Ma CK; Linden MD; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1993 Oct; 100(4):428-32. PubMed ID: 8105676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
    Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunohistochemical investigation of proliferating cell nuclear antigen in bladder cancer].
    Sumiyoshi Y; Inoue Y; Akiyama M
    Nihon Hinyokika Gakkai Zasshi; 1993 Sep; 84(9):1643-8. PubMed ID: 8105131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of cell proliferation in gastric carcinoma: comparative analysis of Ki-67 and proliferative cell nuclear antigen (PCNA).
    Rosa JC; Mendes R; Filipe MI; Morris RW
    Histochem J; 1992 Feb; 24(2):93-101. PubMed ID: 1349600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma.
    Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK
    Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of proliferating cell nuclear antigen, p53, p21, and apoptosis in primary gastric lymphoma.
    Aoyagi K; Kohfuji K; Yano S; Murakami N; Miyagi M; Takeda J; Shirouzu K
    Surgery; 2002 Jul; 132(1):20-6. PubMed ID: 12110791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
    Krauss JS; Pantazis CG; Chandler FW
    Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma.
    Gasparini G; Meli S; Pozza F; Cazzavillan S; Bevilacqua P
    Growth Regul; 1992 Dec; 2(4):145-50. PubMed ID: 1363282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.